Chi3l1 Is a Modulator of Glioma Stem Cell States and a Therapeutic Target in Glioblastoma
Authors:
- Charlotte Guetta-TerrierCGCharlotte Guetta-Terrier
- David KarambiziDKDavid Karambizi
- Bedia AkosmanBABedia Akosman
- John P. ZepeckiJZJohn P. Zepecki
- Jia-Shu ChenJCJia-Shu Chen
- Suchitra KamleSKSuchitra Kamle
- J. Eduardo FajardoJFJ. Eduardo Fajardo
- Andras FiserAFAndras Fiser
- Ritambhara SinghRSRitambhara Singh
- Steven A. TomsSTSteven A. Toms
- Chun Geun LeeCLChun Geun Lee
- Jack A. EliasJEJack A. Elias
Open Access
- 27 April 2023
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 83 (12) , 1984-1999
Abstract
Chitinase 3–like 1 (Chi3l1) is a secreted protein that is highly expressed in glioblastoma. Here, we show that Chi3l1 alters the state of glioma stem cells (GSC) to support tumor growth. Exposure of patient-derived GSCs to Chi3l1 reduced the frequency of CD133+SOX2+ cells and increased the CD44+Chi3l1+ cells. Chi3l1 bound to CD44 and induced phosphorylation and nuclear translocation of β-catenin, Akt, and STAT3. Single-cell RNA sequencing and RNA velocity following incubation of GSCs with Chi3l1 showed significant changes in GSC state dynamics driving GSCs towards a mesenchymal expression profile and reducing transition probabilities towards terminal cellular states. ATAC-seq revealed that Chi3l1 increases accessibility of promoters containing a Myc-associated zinc finger protein (MAZ) transcription factor footprint. Inhibition of MAZ downregulated a set of genes with high expression in cellular clusters that exhibit significant cell state transitions after treatment with Chi3l1, and MAZ deficiency rescued the Chi3L-induced increase of GSC self-renewal. Finally, targeting Chi3l1 in vivo with a blocking antibody inhibited tumor growth and increased the probability of survival. Overall, this work suggests that Chi3l1 interacts with CD44 on the surface of GSCs to induce Akt/β-catenin signaling and MAZ transcriptional activity, which in turn upregulates CD44 expression in a pro-mesenchymal feed-forward loop. The role of Chi3l1 in regulating cellular plasticity confers a targetable vulnerability to glioblastoma. Significance: Chi3l1 is a modulator of glioma stem cell states that can be targeted to promote differentiation and suppress growth of glioblastoma.Keywords
All Related Versions
Funding Information
- Warren Alpert Foundation (17775)
This publication has 49 references indexed in Scilit:
- The NF-κB RelB Protein Is an Oncogenic Driver of Mesenchymal GliomaPLOS ONE, 2013
- Vezf1 protein binding sites genome-wide are associated with pausing of elongating RNA polymerase IIProceedings of the National Academy of Sciences, 2012
- Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomasNeuro-Oncology, 2011
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell SubpopulationsCell, 2010
- Chitinase family GH18: evolutionary insights from the genomic history of a diverse protein familyBMC Ecology and Evolution, 2007
- Complex networks orchestrate epithelial–mesenchymal transitionsNature Reviews Molecular Cell Biology, 2006
- High Serum Concentration of YKL-40 Is Associated with Short Survival in Patients with Acute Myeloid LeukemiaClinical Cancer Research, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- High serum YKL-40 level in patients with small cell lung cancer is related to early deathLung Cancer, 2004
- Identification of proteins secreted by human osteoblastic cells in cultureJournal of Bone and Mineral Research, 1992